CROSSROADS STRATEGIES, LLC for LILLY USA, LLC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the FDA's accelerated approval pathway; PDUFA Reauthorization; FY2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| SHAY MICHAEL HANCOCK | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| BEN LEE MCMAKIN | — |
| CHRIS J MILLER | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Medicare/Medicaid MMM
Issues related to Medicare beneficiary access to diagnostic radiopharmaceutical testing; Facilitating Innovative Nuclear Diagnostics Act of 2021 (H.R.4479/S.2609); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JASON GLEASON | — |
| SHAY MICHAEL HANCOCK | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| MATHEW LAPINSKI | — |
| BEN LEE MCMAKIN | — |
| CHRIS J MILLER | — |
| HUNTER MOORHEAD | — |
| JASON BENJAMIN VAN PELT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.